Saccharomyces cerevisiae, the Baker's Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice

Cancer Immunology, Immunotherapy

Volumn 57, Issue 4, 2008, Pages 581-592

  Ghoneum, Mamdooh ^a   Badr El Din, Nariman K ^b   Noaman, Eman ^c   Tolentino, Lucilene ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Mansoura University   (Egypt)

^c NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY   (Egypt)

Author keywords

Apoptosis; Cytokine; Ehrlich carcinoma; In vivo; S. cerevisiae

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EHRLICH ASCITES TUMOR CELL; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; YEAST;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, EHRLICH TUMOR; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; MICE; SACCHAROMYCES CEREVISIAE;

EID: 38649139147     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0398-9     Document Type: Article

References (76)

1. Ahmed M, Cramer SD, Lyles DS (2004) Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses. Virology 330(1):34-49
2. Arends MJ, Wyllie AH (1991) Apoptosis: mechanisms and roles in pathology. Rev Exp Pathol Int 32:223-254
3. Bae SH, Park YJ, Park JB, Choi YS, Kim MS, Sin JI (2007) Therapeutic synergy of human papillomavirus E7 subunit vaccines plus cisplatin in an animal tumor model: causal involvement of increased sensitivity of cisplatin-treated tumors to CTL-mediated killing in therapeutic synergy. Clin Cancer Res 13(1):341-349
4. Balachandran S, Porosnicu M, Barber GN (2001) Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis. J Virol 75(7):3474-3479
5. Baron S, Tyring SK, Fleischmann WR Jr, Coppenhaver DH, Niesel DW, Klimpel GR, Stanton GJ, Hughes TK (1991) The interferon. Mechanisms of action and clinical applications. JAMA 266:1375-1383
6. Biber JL, Jabbour S, Parihar R, Dierksheide J, Hu Y, Baumann H, Bouchard P, Caligiuri MA, Carson W (2002) Administration of two macrophage-derived interferon-gamma-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon-gamma. Cell Immunol 216(1-2):31-42
7. Borish LC, Steinke JW (2003) Cytokines and chemokines. J Allergy Clin Immunol 111:S460-S475
8. Carson WE, Dierksheide JE, Jabbour S, Anghelina M, Bouchard P, Ku G, Yu H, Baumann H, Shah MH, Cooper MA, Durbin J, Caligiuri MA (2000) Coadministration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: critical role of natural killer cell interferon-gamma production and STAT-mediated signal transduction. Blood 96(4):1465-1473
9. Carson WE, Yu H, Dierksheide J, Pfeffer K, Bouchard P, Clark R, Durbin J, Baldwin AS, Peschon J, Johnson PR, Ku G, Baumann H, Caligiuri MA (1999) A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 162(8):4943-4951
10. Cha SS, Kim MS, Choi YH, Sung BJ, Shin NK, Shin HC, Sung YC, Oh BH (1999) 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11:253-261
11. Farina HG, Pomies M, Alonso DF, Gomez DE (2006) Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 16(4):885-891
12. Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Terrier-Lacombe MJ, Bressac De-Paillerets B, Barrois M, Feunteun J, Kirn DH, Vassal G (2002) Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts. Cancer Res 62(3):764-772
13. Ghoneum M (1998) Anti-HIV activity in vitro of MGN-3, an activated arabinoxylan from rice bran. Biochem Biophys Res Commun 243(1):25-29
14. Ghoneum M (1998) Enhancement of human natural killer cell activity by modified arabinoxylan from rice bran (MGN-3). Int J Immunother XIV(2):89-99
15. Ghoneum M, Abedi S (2004) Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharm Pharmacol 56(12):1581-1588
16. Ghoneum M, Brown J (1999) NK immunorestoration of cancer patients by MGN-3, a modified arabinoxylan rice bran (study of 32 patients followed for up to 4 years). In: Klatz R, Goldman R (eds) Anti-aging medical therapeutics. Vol. III. Health Quest Publications, Marina del Rey, pp 217-226
17. Ghoneum M, Brown J, Gollapudi S (2007) "Yeast therapy for the treatment of cancer and its enhancement by MGN-3/Biobran, an arabinoxylan rice bran" in Apoptosis review. Nova, Hauppague
18. Ghoneum M, Gollapudi S (2004) Induction of apoptosis in human breast cancer cells by Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res 24:1455-1463
19. Ghoneum M, Gollapudi S (2005) Modified arabinoxylan rice bran (MGN-3/Biobran) enhances yeast-induced apoptosis in human breast cancer cells in vitro. Anticancer Res 25:859-870
20. Ghoneum M, Gollapudi S (2005) Synergistic role of arabinoxylan rice bran (MGN-3/Biobran) in S. cerevisiae-induced apoptosis of monolayer breast cancer MCF-7 Cells. Anticancer Res 25:4187-4196
21. Ghoneum M, Gollapudi S (2006) Apoptosis of breast cancer MCF-7 cells in vitro is induced specifically by yeast and not by fungal mycelia. Anticancer Res 26:2013-20222
22. Ghoneum M, Hamilton J, Brown J, Gollapudi S (2005) Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res 25:981-989
23. Ghoneum M, Jewett A (2000) Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Cancer Detect Prev 24(4):314-324
24. Ghoneum M, Matsuura M (2004) Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/biobran). Int J Immunopathol Pharmacol 17(3):283-292
25. Ghoneum M, Wang L, Agrawal S, Gollapudi S (2007) Yeast therapy for the treatment of breast cancer: a nude mice model study. In Vivo 21:251-258
26. Gillet L, Dewals B, Farnir F, de Leval L, Vanderplasschen A (2005) Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo. Cancer Res 65(20):9463-9472
27. Gollob JA, Mier JW, Veenstra K, McDermott DF, Clancy D, Clancy M, Atkins MB (2000) Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response. Clin Cancer Res 6(5):1678-1692
28. Griebel PJ, Ohmann HB, Lawman MJ, Babiuk LA (1990) The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. J Gen Virol 71(Pt 2):369-377
29. Hanson MG, Ozenci V, Carlsten MC, Glimelius BL, Frodin JE, Masucci G, Malmberg KJ, Kiessling RV (2007) A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients. Cancer Immunol Immunother 56(7):973-984
30. Herberman RB (2002) Cancer immunotherapy with natural killer cells. Semin Oncol 29(3 Suppl 7):27-30
31. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D (1994) Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 68(6):3667-3673
32. Hoffmann D, Bayer W, Grunwald T, Wildner O (2007) Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancer. Mol Cancer Ther 6(7):1942-1950
33. Imagawa Y, Satake K, Kato Y, Tahara H, Tsukuda M (2004) Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model. Auris Nasus Larynx 31(3):239-245
34. Kalinski P, Giermasz A, Nakamura Y, Basse P, Storkus WJ, Kirkwood JM, Mailliard RB (2005) Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol Immunol. 42(4):535-539. Review
35. Kapoor S, Pal S, Sahni P, Dattagupta S, Kanti Chattopadhyay T (2005) Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study. J Surg Res 129(2):172-175
36. Katiyar SK, Agarwal R, Mukhtar H (1994) Inhibition of spontaneous and photo-enhanced lipid peroxidation in mouse epidermal microsomes by EC derivatives from green tea. Cancer Lett 79:61-66
37. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a biological phenomena with wide ranging implications in tissue kinetics. Brit J cancer 26:239-257
38. Kim DS, Kim SY, Jeong YM, Jeon SE, Kim MK, Kwon SB, Na JI, Park KC (2006) Light-activated indole-3-acetic acid induces apoptosis in g361 human melanoma cells. Biol Pharm Bull 29(12):2404-2409
39. Kopecky SA, Willingham MC, Lyles DS (2001) Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol 75(24):12169-12181
40. Koyama AH (1995) Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus. Virus Res 37(3):285-290
41. Kumi-Diaka JK, Hassanhi M, Merchant K, Horman V (2006) Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells. J Med Food 9(4):491-497
42. Lee SF, Liang YC, Lin JK (1995) Inhibition of 1,2,4-benzenetriol- generated active oxygen species and induction of phase II enzymes by green tea polyphenols. Chem Biol Interact 98:283-301
43. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM (1993) Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361(6414):739-742
44. Lin EY, Pollard JW (2004) Macrophages: modulators of breast cancer progression. Novartis Found Symp 256:158-168
45. Liu A, Guardino A, Chinsangaram L, Goldstein MJ, Panicali D, Levy R (2007) Therapeutic vaccination against murine lymphoma by intratumoral injection of recombinant fowlpox virus encoding CD40 ligand. Cancer Res. 67(14):7037-7044
46. Lupu CM, Eisenbach C, Lupu AD, Kuefner MA, Hoyler B, Stremmel W, Encke J (2007) Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer. Oncol Rep 18(3):745-748
47. Malafa MP, Fokum FD, Mowlavi A, Abusief M, King M (2002) Vitamin E inhibits melanoma growth in mice. Surgery 131:85-91
48. Marty M, Mignot L, Gisselbrecht G, Morvan F, Gorins A, Boiron M (1985) Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception. Contracept Fertil Sex 13:181-186
49. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z et al (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. Jama 271(24):1913-1918
50. Mills KH, Greally JF, Temperley IJ, Mullins GM (1980) Haematological and immune suppressive effects of total body irradiation in the rat. Ir J Med Sci 149:201-208
51. Murphy D, Detjen KM, Welzel M, Wiedenmann B, Rosewicz S (2001) Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases. Hepatology 33(2):346-356
52. Neuzil J (2003) Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer 89:1822-1826
53. Parshad R, Hazrah P, Kumar S, Gupta SD, Ray R, Bal S (2005) Effect of preoperative short course famotidine on TILs and survival in breast cancer. Indian J Cancer 42(4):185-190
54. Parshad R, Kapoor S, Gupta SD, Kumar A, Chattopadhyaya TK (2002) Does famotidine enhance tumor infiltrating lymphocytes in breast cancer? Results of a randomized prospective pilot study. Acta Oncol 41(4):362-365
55. Pelizon AC, Kaneno R, Soares AM, Meira DA, Sartori A (2005) Immunomodulatory activities associated with beta-glucan derived from Saccharomyces cerevisiae. Physiol Res. 54(5):557-564
56. Pfluger P, Kluth D, Landes N, Bumke-Vogt C, Brigelius-Flohe R (2004) Vitamin E: underestimated as an antioxidant. Redox Rep 9(5):249-254 Review
57. Rahim SS, Khan N, Boddupalli CS, Hasnain SE, Mukhopadhyay S (2005) Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells also involves c-rel transcription factor. Immunology 114(3):313-321
58. Raychaudhuri B, Fisher CJ, Farver CF, Malur A, Drazba J, Kavuru MS, Thomassen MJ (2000) Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine 12(9):1348-1355
59. Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M (2006) Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer. 118(7):1635-1644
60. Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, zur Hausen H (1998) Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol 72(12):9470-9478
61. Sanderson BJ, Ferguson LR, Denny WA (1996) Mutagenic and carcinogenic properties of platinum-based anticancer drugs. Mutat Res 355:59-70
62. Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman J, Pecorelli S, Cannon M, Parham GP (2000) Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 48:997-1006
63. Sasagawa T, Hlaing M, Akaike T (2000) Synergistic induction of apoptosis in murine hepatoma Hepa1-6 cells by IFN-gamma and TNF-alpha. Biochem Biophys Res Commun 272(3):674-680
64. Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N, Bell JC (2000) Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6(7):821-825
65. Suk K, Kim YH, Chang I, Kim JY, Choi YH, Lee KY, Lee MS (2001) IFNalpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation. FEBS Lett 495:66-70
66. Surawicz CM, McFarland LV, Elmer G, Chinn J (1989) Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 84(10):1285-1287
67. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R (1993) Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol 74(Pt 11):2347-2355
68. Tribukait B, Moberger G, Zetterberg A (1975) Methodological aspects of rapid flow cytofluorometry for DNA analysis of human urinary bladder cells. In: Pulse-Cytophotometry, part I. European press, Medicon, Ghent, Belgium, pp 50-60
69. Turnquist HR, Lin X, Ashour AE, Hollingsworth MA, Singh RK, Talmadge JE, Solheim JC (2007) CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity. Int J Oncol 30(3):631-639
70. Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1995) Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem. 270(16):9558-9563
71. Weisfuse IB, Graham DJ, Will M, Parkinson D, Snydman DR, Atkins M, Karron RA, Feinstone S, Rayner AA, Fisher RI, et al (1990) An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells. J Infect Dis 161(4):647-652
72. Wenk R, Bertolino M, Ochoa J, Cullen C, Bertucelli N, Bruera E (2000) Laxative effects of fresh baker's yeast. J Pain Symptom Manage 19(3):163-164
73. Whitsett TG Jr, Lamartiniere CA (2006) Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert Rev Anticancer Ther 6(12):1699-1706
74. Whitworth PW, Pak CC, Esgro J, Kleinerman ES, Fidler IJ (1990) Macrophages and cancer. Cancer Metastasis Rev 8(4):319-351
75. Yano H, Iemura A, Haramaki M, Ogasawara S, Takayama A, Akiba J, Kojiro M (1999) Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Hepatology 29(6):1708-1717
76. Yeh TC, Chiang PC, Li TK, Hsu JL, Lin CJ, Wang SW, Peng CY, Guh JH (2007) Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem Pharmacol. 73(6):782-792